
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
INSTRUMENT ONLY TEMPLATE
A. 510(k) Number:
K111356
B. Purpose for Submission:
To determine substantial equivalence for the ASiManager-AT
C. Manufacturer and Instrument Name:
Arlington Scientific Inc. ASiManager-AT
D. Type of Test or Tests Performed:
Digital interpretation of visual results obtained with ASI RPR card test for syphilis
E. System Descriptions:
1. Device Description:
The ASiManager-AT is an integrated digital particle analyzer designed to
objectively interpret certain slide agglutination tests manufactured by Arlington
Scientific, Inc. (ASI). Qualitative and semi quantitative tests are performed by
laboratory professionals who use the ASiManager-AT to provide standardized test
interpretation using criteria that define reactive and nonreactive agglutination
reactions. The ASiManager-AT also delivers an initial predictive titer analysis
for the ASI RPR Card Test for Syphilis.
The ASiManager-AT consists of :
• A Computer/Monitor
• Imaging Unit and Drawers
• Wireless Keyboard and Mouse
• Monitor Cables and Power Adaptor
• ASiManager-AT Calibration Check Cards
2. Principles of Operation:
The ASiManager-AT employs a CCD (charge-coupled device) camera that uses
light reflectance to create a highly sensitive and high-resolution image of the
agglutination immunoassay. This image is then analyzed by the proprietary
software algorithm to interpret the agglutination pattern. The instrument
1

--- Page 2 ---
compares the high resolution digital picture of each well to built in preset
parameters and reports the results as reactive or non reactive. A numerical index
of < 800 is recorded as non reactive and a numerical index of > 801 is recorded as
reactive. The ASiManager-AT further provides tools that enable the creation,
storage, retrieval and transmittal of the test results.
3. Modes of Operation:
The ASiManager-AT is an instrument that has an integrated PC and preloaded
software. The instrument uses a CCD camera at a precise focal point to capture
the image of a test circle on ASI’s particle agglutination test cards. The image
results are passed to an integrated PC and software to provide an easy to use
application for reviewing and distributing results.
4. Specimen Identification:
The Asi RPR card test for syphilis is first performed correctly and results read
prior to being analyzed by the ASiManager-AT.
5. Specimen Sampling and Handling:
After performing the ASI RPR Card Test for syphilis tests, the RPR card is
inserted into the device holder of the ASiManager-AT. The Multi Sample
Measuring Mode in the instrument allows for examinations on the basis of sample
ID numbers. The software automatically inserts the sample ID numbers into a
worklist. Then the test is run and results can be viewed singly.
6. Calibration:
ASiManager-AT Calibration Check Cards are provided with the system and may
be used at user’s convenience as an aid to ensure that the instrument is performing
as expected. ASI recommends that the ASiManager-AT Calibration Check Cards
be used after the initial set-up and periodically as needed.
7. Quality Control:
Quality control requirements must be performed in accordance with applicable
local, state and/or federal regulations or accreditation requirements and the
laboratory’s standard Quality Control Procedures. Controls with graded reactivity
should be included. If control samples do not yield the expected response, the
assay should be considered invalid and the assay repeated. If the repeat assay
does not elicit the expected results for the control samples, the user should
discontinue use and contact ASI Technical Support.
2

--- Page 3 ---
8. Software:
FDA has reviewed applicant’s Hazard Analysis and Software Development
processes for this line of product types:
Yes ___X____ or No________
F. Regulatory Information:
1. Regulation section:
21 CFR 862.2400 – Densitometer/scanner (integrating, reflectance, TLC, or
radiochromatogram) for clinical use
2. Classification:
Class I
3 Product code:
JQT
4. Panel:
Clinical Chemistry
G. Intended Use:
1. Indication(s) for Use:
The ASiManger-AT is intended to be used as an integrated digital particle
analyzer to objectively interpret the ASI RPR Card Test for syphilis. The
ASiManger-AT is designed to provide standardized test interpretation, an initial
predictive titer analysis, and provides for storage, retrieval and transmittal of the
test results. It is intended to be acquired, possessed and used only by healthcare
professionals. For in vitro Diagnostic Use Only, not intended for screening blood
and tissue donors.
2. Special Conditions for Use Statement:
It is intended to be acquired, possessed and used only by healthcare professionals.
3

--- Page 4 ---
H. Substantial Equivalence Information:
1. Predicate Device Name and 510(k) number:
ASI RPR Card Test for syphilis – K851504
2. Comparison with Predicate Device:
Similarities
Item Device Predicate
Intended Use To interpret results of the Same
ASI RPR Card Test for
syphilis
Differences
Item Device Predicate
Result Interpretation Interprets slide Interprets slide
agglutination tests agglutination tests
objectively with digital visually
particle analyzer
Function Create, store, retrieve and N/A
transmit test results
I. Special Control/Guidance Document Referenced:
N/A
J. Performance Characteristics:
1. Analytical Performance:
a. Accuracy
Analytical specificity and accuracy over a wide range of known titers, was
evaluated using samples of known reactivity. The ASiManager-AT identified the
1802 reactive samples and the 1617 nonreactive samples correctly. The
ASiManager-AT also identified the 700 of 708 titer samples within ±1 dilution
titer, with titers ranging from 1:1 to 1:1024 correctly.
b. Precision/Reproducibility:
Repeatability is defined as the variation in measurements taken by a single
instrument on the same item and under the same conditions.
A total of 10 samples using the ASI RPR Card Test for Syphilis and the
ASiManager-AT were evaluated for reactivity, predictive titer, and end-point titer.
4

[Table 1 on page 4]
Similarities								
	Item			Device			Predicate	
Intended Use			To interpret results of the
ASI RPR Card Test for
syphilis			Same		

[Table 2 on page 4]
Differences								
	Item			Device			Predicate	
Result Interpretation			Interprets slide
agglutination tests
objectively with digital
particle analyzer			Interprets slide
agglutination tests
visually		
Function			Create, store, retrieve and
transmit test results			N/A		

--- Page 5 ---
The testing requirements were as follows:
1. All qualitative and semiquantitative testing was conducted according to the
procedure in the package insert.
2. Each qualitative sample was tested 100 times.
3. Immediately after the testing of each card was completed the results were
visually interpreted.
4. The end-point titer was determined for all reactive samples 10 times.
5. After visual interpretation the test card was placed in the ASiManager-AT for
analysis.
6. The predictive titer was determined by the ASiManager-AT using only the
undiluted sample.
7. All reactive samples had their end-point titers determined by the ASiManager-
AT.
A total of 10 samples were evaluated to determine repeatability of reactivity and end-
point titer. Of the 10 samples, 5 were reactive and 5 were nonreactive visually. The
reactive samples had titers of 1, 2, 4, 8 and 32. Each of the 10 samples was repeated
100+ times to evaluate the reactivity and predictive titer using the ASiManager-AT.
Refer to Table 18.8 below
Table 18.8
Sample Predictive Titer % Concordance
1 1:1 100/100 100%
2 1:2 83/100 83%
3 1:4 102/110 93%
4 1:8 90/100 90%
5 1:32 74/110 67%
6 NR 100/100 100%
7 NR 100/100 100%
8 NR 100/100 100%
9 NR 100/100 100%
10 NR 100/100 100%
5

[Table 1 on page 5]
Sample	Predictive Titer		% Concordance
1	1:1	100/100	100%
2	1:2	83/100	83%
3	1:4	102/110	93%
4	1:8	90/100	90%
5	1:32	74/110	67%
6	NR	100/100	100%
7	NR	100/100	100%
8	NR	100/100	100%
9	NR	100/100	100%
10	NR	100/100	100%

--- Page 6 ---
Since the predictive titer is estimated from only the undiluted specimen, it is acceptable
that the result range above 1:1 is within ±1 dilution. The results within ±1 dilution are in
Table 18.9.
Table 18.9
Sample Predictive Titer within ±1 titer % Concordance
1 1:1 100/100 100%
2 1:2 100/100 100%
3 1:4 110/110 100%
4 1:8 100/100 100%
5 1:32 98/110 89%
6 NR 100/100 100%
7 NR 100/100 100%
8 NR 100/100 100%
9 NR 100/100 100%
10 NR 100/100 100%
The end-point titers of the 5 reactive samples were determined by the ASiManager-AT
and were repeated 10 times. The results are contained in Table 18.10
Table 18.10
Sample End-point Titer % Concordance
1 1:1 10/10 100%
2 1:2 10/10 100%
3 1:4 10/10 100%
4 1:8 10/10 100%
5 1:32 10/10 100%
The data above show that the ASiManager-AT gives an objective and standardized
interpretation of the test results with a high degree of repeatability. There is some
variability in the predictive titer due to its interpretation by the undiluted specimen only.
Giving the allowance of ±1 dilution titer the repeatability was greatly improved.
The actual end-point titer has a high degree of repeatability.
Additional repeatability testing was done in-house. The testing consisted of: three
samples, a RPR nonreactive sample, an RPR reactive 1:1 titered sample (minimum
cutoff) and a RPR reactive 1:4 titered sample (moderate reaction).Each sample was tested
each morning for twelve days by an operator with experience in performing the ASI RPR
Card Test for Syphilis and operating the ASiManager-AT. Each sample was tested each
afternoon for twelve days by a different operator with experience in performing the ASI
RPR Card Test for Syphilis and operating the ASiManager-AT. Each of the three samples
was run in triplicate on the morning and afternoon runs. Testing was performed on the
same ASiManager-AT.
The results of the testing are contained in Table 18-11 below
6

[Table 1 on page 6]
Sample	Predictive Titer within ±1 titer		% Concordance
1	1:1	100/100	100%
2	1:2	100/100	100%
3	1:4	110/110	100%
4	1:8	100/100	100%
5	1:32	98/110	89%
6	NR	100/100	100%
7	NR	100/100	100%
8	NR	100/100	100%
9	NR	100/100	100%
10	NR	100/100	100%

[Table 2 on page 6]
Sample	End-point Titer		% Concordance
1	1:1	10/10	100%
2	1:2	10/10	100%
3	1:4	10/10	100%
4	1:8	10/10	100%
5	1:32	10/10	100%

--- Page 7 ---
Table 18-11
%
Sample Expected Results Agreement
Positive
ASiManager-AT #3
Date 7/28 7/29 8/1 8/2 8/3 8/4 8/5 8/8 8/9 8/10 8/11 8/12
Operator 1
1 NR NR NR NR NR NR NR NR NR NR NR NR NR
NR NR NR NR NR NR NR NR NR NR NR NR NR 100%
NR NR NR NR NR NR NR NR NR NR NR NR NR
2 1:1 1:1 1:1 1:1 1:1 1:1 NR 1:1 1:1 1:1 1:1 1:1 1:1
1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 97.2%
1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1
3 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4
1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 100%
1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4
Operator 2
1 NR NR NR NR NR NR NR NR NR NR NR NR NR
NR NR NR NR NR NR NR NR NR NR NR NR NR 100%
NR NR NR NR NR NR NR NR NR NR NR NR NR
2 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1
1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 NR 1:1 1:1 94.4%
1:1 1:1 1:1 1:1 1:1 1:1 NR 1:1 1:1 1:1 1:1 1:1 1:1
3 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4
1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 100%
1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4
The data shows a high degree of repeatability.
Reproducibility
Reproducibility is defined as the variation in measurements taken by multiple instruments
on the same item and under the same conditions.
The interpretation of 12 samples using the ASI RPR Card Test for Syphilis and the
ASiManager-AT were evaluated for reactivity and predictive titer. The testing
requirements were as follows:
All qualitative and semiquantitative testing was conducted using the procedure in the
package insert.
Each sample was tested 10 times.
After the testing was completed the results were visually interpreted.
After visual interpretation the test card was placed in the ASiManager-AT for analysis.
The predictive titer was determined by the ASiManager-AT using only the undiluted
sample.
After the analysis in the first ASiManager-AT, the same test card was placed into another
ASiManager-AT and then repeated through 4 instruments.
A total of 12 samples were evaluated to determine reproducibility of reactivity and end-
point titer among the four instruments. Of the 12 samples, 9 were reactive and 3 were
7

[Table 1 on page 7]
Sample	Expected	Results												%
Agreement
Positive
		ASiManager-AT #3												
	Date	7/28	7/29	8/1	8/2	8/3	8/4	8/5	8/8	8/9	8/10	8/11	8/12	
Operator 1														
1	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	100%
	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	
	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	
2	1:1	1:1	1:1	1:1	1:1	1:1	NR	1:1	1:1	1:1	1:1	1:1	1:1	97.2%
	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	
	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	
3	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	100%
	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	
	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	
Operator 2														
1	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	100%
	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	
	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	
2	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	94.4%
	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	NR	1:1	1:1	
	1:1	1:1	1:1	1:1	1:1	1:1	NR	1:1	1:1	1:1	1:1	1:1	1:1	
3	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	100%
	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	
	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	

--- Page 8 ---
nonreactive visually. The reactive samples had titers ranging from 1:1 to 1:16. Each of
the 12 samples was analyzed once on each of the four instruments to evaluate the
reactivity and predictive titer. The data are shown in the Table 18-12 below.
Table 18-12
Sample Expected Results within ±1 Titer % Concordance
ASiM-2 ASiM-3 ASiM-4 ASiM-5
1 NR 10/10 10/10 10/10 10/10 100%
2 NR 10/10 10/10 10/10 10/10 100%
3 NR 10/10 10/10 9/10 10/10 97.5%
4 1:1 10/10 8/10 9/10 9/10 90%
5 1:1 10/10 10/10 10/10 10/10 100%
6 1:2 10/10 10/10 10/10 10/10 100%
7 1:4 10/10 9/10 9/10 9/10 92.5%
8 1:4 10/10 10/10 10/10 10/10 100%
9 1:4 10/10 10/10 10/10 9/10 97.5%
10 1:4 10/10 10/10 10/10 10/10 100%
11 1:8 10/10 10/10 10/10 10/10 100%
12 1:16 10/10 10/10 10/10 10/10 100%
Totals 120/120 117/120 117/120 117/120 98.1%
The data above show that the ASiManager-AT gives an objective and standardized
interpretation of the test results with good reproducibility. There was some variability in
the predictive titer due to it being interpreted on the undiluted specimen only. However
with the allowance of ±1 dilution titer, the reproducibility is greatly improved.
Additional reproducibility testing was conducted at 3 outside sites and in-house.
Testing was conducted on 10 samples, consisting of three RPR nonreactive samples, four
RPR reactive 1:1 titered samples (minimum cutoff) and three RPR reactive 1:4 titered
samples (moderate reaction).
Each sample was tested on two consecutive days by a different operator with experience
in performing the ASI RPR Card Test for Syphilis and operating the ASiManager-AT.
Each of the three samples was run in triplicate.
The results of the testing are contained in Table 18-15:
8

[Table 1 on page 8]
Sample	Expected	Results within ±1 Titer				% Concordance
		ASiM-2	ASiM-3	ASiM-4	ASiM-5	
1	NR	10/10	10/10	10/10	10/10	100%
2	NR	10/10	10/10	10/10	10/10	100%
3	NR	10/10	10/10	9/10	10/10	97.5%
4	1:1	10/10	8/10	9/10	9/10	90%
5	1:1	10/10	10/10	10/10	10/10	100%
6	1:2	10/10	10/10	10/10	10/10	100%
7	1:4	10/10	9/10	9/10	9/10	92.5%
8	1:4	10/10	10/10	10/10	10/10	100%
9	1:4	10/10	10/10	10/10	9/10	97.5%
10	1:4	10/10	10/10	10/10	10/10	100%
11	1:8	10/10	10/10	10/10	10/10	100%
12	1:16	10/10	10/10	10/10	10/10	100%
Totals		120/120	117/120	117/120	117/120	98.1%

--- Page 9 ---
Table 18-15
% Agreement
Sample Expected Results
Positive
Arlington Qualtex Mississippi Georgia Dept.
Scientific Valley Health
Day 1 Day 2 Day Day Day Day Day 1 Day 2
1 2 1 2
1 NR NR NR NR NR NR NR NR NR 100%
2 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 100%
3 NR NR NR NR NR NR NR NR NR 100%
4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 100%
5 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 100%
6 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 1:4 100%
7 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 100%
8 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 100%
9 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 1:1 100%
10 NR NR NR NR NR NR NR NR NR 100%
The data shows a high degree of reproducibility.
c. Linearity:
N/A
d. Carryover:
N/A
e. Interfering Substances:
N/A
2. Other Supportive Instrument Performance Data Not Covered Above:
The digital interpretation of the results by the ASiManager-AT instrument was
compared to the visual interpretation of the results of samples tested at 3 sites
with the ASI RPR Card Test for Syphilis. Results are as follows:
9

[Table 1 on page 9]
Sample	Expected	Results								% Agreement
Positive
										
		Arlington
Scientific		Qualtex		Mississippi
Valley		Georgia Dept.
Health		
		Day 1	Day 2	Day
1	Day
2	Day
1	Day
2	Day 1	Day 2	
1	NR	NR	NR	NR	NR	NR	NR	NR	NR	100%
2	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	100%
3	NR	NR	NR	NR	NR	NR	NR	NR	NR	100%
4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	100%
5	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	100%
6	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	1:4	100%
7	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	100%
8	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	100%
9	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	1:1	100%
10	NR	NR	NR	NR	NR	NR	NR	NR	NR	100%

--- Page 10 ---
Combined Prospective Sample Testing - 375 samples
ASiManager-AT Digital Results
Reactive Nonreactive
3 0
Reactive
Visual
Results
Nonreactive 0 372
These results give a percent agreement positive of 100% with reactive samples and 100%
with nonreactive samples.
Combined Retrospective Sample Testing - 3131 Samples
ASiManager-AT Digital Results
Reactive Nonreactive
1799 58
Reactive
Visual
Results
Nonreactive 29 1245
These results give a percent agreement positive of 98.4% with reactive samples and
95.5% with nonreactive samples.
K. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
L. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
10

[Table 1 on page 10]
ASiManager-AT Digital Results
Reactive Nonreactive
3 0
Reactive
Visual
Results
Nonreactive 0 372			
		Reactive	Nonreactive
	Reactive	3	0
	Nonreactive	0	372

[Table 2 on page 10]
ASiManager-AT Digital Results
Reactive Nonreactive
1799 58
Reactive
Visual
Results
Nonreactive 29 1245			
		Reactive	Nonreactive
	Reactive	1799	58
	Nonreactive	29	1245